US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Polyrizon Ltd.

1.05

+0.01000.96%

Pre-market: 1.02-0.0300-2.86%05:00 EDT

Volume:4.50M

Turnover:4.32M

Market Cap:5.59M

PE:- -

High:1.05

Open:0.9200

Low:0.8571

Close:1.04

Loading ...

Overview Company News Filings

Polyrizon retains Nasdaq listing following hearings panel

Polyrizon Ltd. Retains Nasdaq Listing After Addressing Compliance Concerns, Aims to Regain Minimum Bid Price by October 2025

Polyrizon Retains Nasdaq Listing Following Hearings Panel

THOMSON REUTERS

Polyrizon Ltd. Announces Board Changes and Confirms Independent Directors

Polyrizon Ltd. Announces Resignation of Board Member Omer Srugo and Confirms Independent Directors

Polyrizon Ltd. Announces Promising Preclinical Results for Innovative Intranasal Hydrogel Platform Targeting CNS Therapeutics

Polyrizon Ltd trading halted, news pending

Polyrizon Receives Nasdaq Delisting Notice

MT Newswires Live

Polyrizon Ltd. Receives Nasdaq Delisting Notice, Plans to Request Hearing to Stay Delisting

Polyrizon Announces Receipt of Nasdaq Delisting Notice

THOMSON REUTERS

Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025

Polyrizon Ltd: Will Effect a Reverse Share Split of the Company’s Ordinary Shares at the Ratio of 1-for-250

THOMSON REUTERS

Polyrizon Ltd. Announces 1-for-250 Reverse Stock Split Effective May 27, 2025

Polyrizon announces preclinical data on nasal protection platform

Polyrizon Ltd. Reports Promising Preclinical Results for Nasal Protection Platform with Strong Mucoadhesion and Surface Coverage

Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises

Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales

Polyrizon Ltd. Initiates Preclinical Studies for Innovative Intranasal Benzodiazepine Treatment Targeting $3.15 Billion Epilepsy Market

Polyrizon Targets $3.15B Epilepsy Market With Preclinical Studies for Innovative Rescue Treatment

THOMSON REUTERS

Polyrizon Shares Surge After Dropping Reverse Stock Split Plan

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PLRZ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PLRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","market":"US","secType":"STK","nameCN":"Polyrizon Ltd.","latestPrice":1.05,"timestamp":1752696000000,"preClose":1.04,"halted":0,"volume":4498866,"hourTrading":{"tag":"盘前","latestPrice":1.02,"preClose":1.05,"latestTime":"05:00 EDT","volume":2558,"amount":2639.2799384,"timestamp":1752742839319},"delay":0,"floatShares":5328000,"shares":5328000,"eps":0,"marketStatus":"Pre-Mkt","change":0.01,"latestTime":"07-17 05:12:02 EDT","open":0.92,"high":1.05,"low":0.8571,"amount":4319864.6697054,"amplitude":0.185481,"askPrice":1.02,"askSize":100,"bidPrice":0.95,"bidSize":511,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1752759000000},"marketStatusCode":1,"adr":0,"listingDate":1730174400000,"exchange":"NASDAQ","adjPreClose":1.05,"preHourTrading":{"tag":"盘前","latestPrice":1.02,"preClose":1.05,"latestTime":"05:00 EDT","volume":2558,"amount":2639.2799384,"timestamp":1752742839319},"postHourTrading":{"tag":"盘后","latestPrice":1.01,"preClose":1.05,"latestTime":"19:59 EDT","volume":250228,"amount":256603.28,"timestamp":1752710395659},"volumeRatio":0.18475314474806667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PLRZ\",,,,,undefined,":{"symbol":"PLRZ","floatShares":5328000,"roa":"-26.65%","roe":"-57.83%","lyrEps":0,"volumeRatio":0.18475314474806667,"shares":5328000,"dividePrice":0,"high":1.05,"amplitude":0.185481,"preClose":1.04,"low":0.8571,"week52Low":0.55,"pbRate":"1.06","week52High":1200,"institutionHeld":0,"latestPrice":1.05,"committee":0.672668,"eps":0,"divideRate":0,"volume":4498866,"delay":0,"ttmEps":0,"open":0.92,"prevYearClose":542.5,"prevWeekClose":0.707,"prevMonthClose":0.7389,"prevQuarterClose":0.7389,"fiveDayClose":0.7133,"twentyDayClose":0.8022,"sixtyDayClose":88.975},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PLRZ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551164297","title":"Polyrizon retains Nasdaq listing following hearings panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2551164297","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551164297?lang=en_us&edition=fundamental","pubTime":"2025-07-15 20:00","pubTimestamp":1752580831,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) received a notification letter from the Nasdaq Hearings Panel granting the Company’s request for the continued listing of its secu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-retains-nasdaq-listing-following-hearings-panel-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-retains-nasdaq-listing-following-hearings-panel-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BKPKM429.USD","NVIW.SI","NDAQ","QID","USAW.SI","USJW.SI","PSQ","PLRZ","IE00BGHQF748.EUR","TSYW.SI","LU2210150020.SGD","MNQmain",".IXIC","BK4585","BK4112","SQQQ","NQmain","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","TQQQ","LU2210149790.SGD","LU2095319765.USD","BK4588","QLD"],"gpt_icon":0},{"id":"2551164665","title":"Polyrizon Ltd. Retains Nasdaq Listing After Addressing Compliance Concerns, Aims to Regain Minimum Bid Price by October 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2551164665","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551164665?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:55","pubTimestamp":1752580515,"startTime":"0","endTime":"0","summary":"Raanana, Israel, July 15, 2025 - Polyrizon Ltd. , a biotech company specializing in intranasal hydrogels, has successfully retained its listing on the Nasdaq Capital Market. Following a hearing on June 26, 2025, the Nasdaq Hearings Panel granted Polyrizon's request to continue its listing, provided the company complies with the Minimum Bid Price Rule by October 17, 2025. The company has committed to avoiding complex or dilutive financing instruments in future capital-raising activities and is implementing an internal control framework to ensure compliance with Nasdaq standards. CEO Tomer Izraeli expressed optimism about enhancing shareholder value and strengthening the company's business position.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nNDL6pH2kp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B64PRP62.GBP","LU2095319765.USD","IE00B3QW5Z07.USD","BK4585","LU2210149790.SGD","PLRZ","BK4112","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2551916461","title":"Polyrizon Retains Nasdaq Listing Following Hearings Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2551916461","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551916461?lang=en_us&edition=fundamental","pubTime":"2025-07-15 19:55","pubTimestamp":1752580500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nTUA3NSRGC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2548604823","title":"Polyrizon Ltd. Announces Board Changes and Confirms Independent Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2548604823","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548604823?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:48","pubTimestamp":1751316489,"startTime":"0","endTime":"0","summary":"An update from Polyrizon Ltd. ( ($PLRZ) ) is now available. On June 25, 2025, Polyrizon Ltd., a company with a focus on innovative solutions, annou...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-announces-board-changes-and-confirms-independent-directors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-announces-board-changes-and-confirms-independent-directors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2548105980","title":"Polyrizon Ltd. Announces Resignation of Board Member Omer Srugo and Confirms Independent Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2548105980","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548105980?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:16","pubTimestamp":1751314562,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. announced that Omer Srugo has resigned from its Board of Directors, effective immediately. The company clarified that his departure was not due to any disagreements with the company's operations or management. Additionally, the Board has identified Asaf Itzhaik, Liat Sidi, Yehonatan Zalman Vinokur, and Liron Carmel as independent members in accordance with Nasdaq listing rules.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL4lVdCw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2542516604","title":"Polyrizon Ltd. Announces Promising Preclinical Results for Innovative Intranasal Hydrogel Platform Targeting CNS Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2542516604","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542516604?lang=en_us&edition=fundamental","pubTime":"2025-06-12 19:32","pubTimestamp":1749727934,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. Announces Promising Preclinical Results for Innovative Intranasal Hydrogel Platform Targeting CNS Therapeutics. Polyrizon Ltd. , a biotechnology company specializing in intranasal drug delivery systems, has announced promising preclinical results from its recent study on the Trap & Target (T&T) platform, an innovative hydrogel-based formulation. Conducted in collaboration with the University of Parma, Italy, the study demonstrated successful targeted deposition in the upper nasal cavity, crucial for central nervous system  drug delivery. The hydrogel formulation achieved over 60% preferential accumulation in areas favorable for nose-to-brain transport, indicating potential applications for CNS-related conditions such as opioid overdose and epileptic seizures. Polyrizon plans to continue preclinical development and initiate safety studies to further validate these findings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intellig","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL73LSSd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2095319765.USD","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","PLRZ","IE00BKPKM429.USD","BK4588","BK4585","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2537163534","title":"Polyrizon Ltd trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2537163534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537163534?lang=en_us&edition=fundamental","pubTime":"2025-05-24 07:50","pubTimestamp":1748044222,"startTime":"0","endTime":"0","summary":"19:50 EDT Polyrizon (PLRZ) Ltd trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-ltd-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2537573691","title":"Polyrizon Receives Nasdaq Delisting Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2537573691","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537573691?lang=en_us&edition=fundamental","pubTime":"2025-05-24 05:00","pubTimestamp":1748034028,"startTime":"0","endTime":"0","summary":"Polyrizon  said Friday it received a delisting notice from Nasdaq.Nasdaq's staff decided to delist the company's securities following a review of its public filings with the SEC.The decision was based on the company's issuance of securities under a March 31 purchase agreement, specifically Series A warrants exercisable on an alternate cashless basis, which Nasdaq said raised public interest concerns due to substantial dilution of shareholders.The company said it plans to request a hearing before the Nasdaq Hearings Panel.Shares of Polyrizon were down nearly 6% in after-hours trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2210150020.SGD","IE00B64PRP62.GBP","PLRZ","IE00B3QW5Z07.USD","NDAQ","BK4588",".IXIC","LU2095319765.USD","NQmain","BK4585","IE00BKPKM429.USD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4112"],"gpt_icon":1},{"id":"2537154061","title":"Polyrizon Ltd. Receives Nasdaq Delisting Notice, Plans to Request Hearing to Stay Delisting","url":"https://stock-news.laohu8.com/highlight/detail?id=2537154061","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537154061?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:15","pubTimestamp":1748031311,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd., a biotech company specializing in intranasal hydrogels, has announced that it received a delisting notice from Nasdaq. The delisting is due to concerns over substantial shareholder dilution following the issuance of securities related to a purchase agreement dated March 31, 2025. Although the company's shares are not immediately affected, Polyrizon plans to request a hearing before a Nasdaq Hearings Panel to address the issue. This request will temporarily halt any suspension or delisting actions until the hearing and a subsequent decision by the Panel.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via GlobeNewswire  on May 23, 2025, and is ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDLCrly:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LU2210150020.SGD","BK4112","BK4588","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2095319765.USD","NDAQ","BK4585","IE00B3QW5Z07.USD","PLRZ","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2537775154","title":"Polyrizon Announces Receipt of Nasdaq Delisting Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2537775154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537775154?lang=en_us&edition=fundamental","pubTime":"2025-05-24 04:15","pubTimestamp":1748031300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nTUABDWZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2537942455","title":"Polyrizon Ltd. Announces Reverse Share Split Effective May 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537942455","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537942455?lang=en_us&edition=fundamental","pubTime":"2025-05-22 21:42","pubTimestamp":1747921377,"startTime":"0","endTime":"0","summary":"An update from Polyrizon Ltd. ( ($PLRZ) ) is now available. Polyrizon Ltd. has announced a reverse share split of its ordinary shares at a 1-for-25...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-announces-reverse-share-split-effective-may-27-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-announces-reverse-share-split-effective-may-27-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2537941229","title":"Polyrizon Ltd: Will Effect a Reverse Share Split of the Company’s Ordinary Shares at the Ratio of 1-for-250","url":"https://stock-news.laohu8.com/highlight/detail?id=2537941229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537941229?lang=en_us&edition=fundamental","pubTime":"2025-05-22 21:28","pubTimestamp":1747920507,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nFWN3RU0VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2537941293","title":"Polyrizon Ltd. Announces 1-for-250 Reverse Stock Split Effective May 27, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537941293","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537941293?lang=en_us&edition=fundamental","pubTime":"2025-05-22 21:27","pubTimestamp":1747920452,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. has announced it will implement a reverse share split at a ratio of 1-for-250, consolidating every 250 ordinary shares into one. This change will take effect on May 27, 2025, when trading on the Nasdaq Capital Market will begin under the new share structure. The reverse split will adjust the number of issued and outstanding shares from 1,332,083,023 to 5,328,332. The company's authorized share capital will remain the same, and fractional shares will be rounded to the nearest whole number.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL4Vw8CV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLRZ"],"gpt_icon":0},{"id":"2537498732","title":"Polyrizon announces preclinical data on nasal protection platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2537498732","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537498732?lang=en_us&edition=fundamental","pubTime":"2025-05-21 19:15","pubTimestamp":1747826137,"startTime":"0","endTime":"0","summary":"Polyrizon (PLRZ) announced compelling results from recent ex vivo studies demonstrating the mucoadhesive strength and extensive nasal surface cover...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/polyrizon-announces-preclinical-data-on-nasal-protection-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/polyrizon-announces-preclinical-data-on-nasal-protection-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2537982161","title":"Polyrizon Ltd. Reports Promising Preclinical Results for Nasal Protection Platform with Strong Mucoadhesion and Surface Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2537982161","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537982161?lang=en_us&edition=fundamental","pubTime":"2025-05-21 19:10","pubTimestamp":1747825812,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. Reports Promising Preclinical Results for Nasal Protection Platform with Strong Mucoadhesion and Surface Coverage. Polyrizon Ltd. , a development stage biotech company, has announced positive preclinical data for its nasal protection platform. The company conducted ex vivo studies in collaboration with Prof. Fabio Sonvico's laboratory, utilizing excised rabbit nasal mucosa to assess the surface coverage and mucoadhesive performance of its proprietary intranasal hydrogel formulation. The studies demonstrated that Polyrizon's formulation rapidly spreads and uniformly covers the nasal mucosa, forming a consistent surface layer. The formulation also exhibited strong and lasting mucoadhesion, even under simulated physiological nasal fluid flow conditions. These findings suggest the potential for effective localized protection or therapeutic delivery, enhancing the formulation's potential efficacy in real-world scenarios.Disclaimer: This news brief was created by Public Techno","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250521:nNDL9rcw8K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","IE00B3QW5Z07.USD","BK4588","LU2095319765.USD","PLRZ","LU2210150020.SGD","BK4585","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2536682396","title":"Polyrizon Ltd. Increases Outstanding Shares Following Warrant Exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2536682396","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536682396?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:58","pubTimestamp":1747659519,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. ( ($PLRZ) ) has issued an announcement. Polyrizon Ltd. has announced an increase in its issued and outstanding ordinary shares, whic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-increases-outstanding-shares-following-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/polyrizon-ltd-increases-outstanding-shares-following-warrant-exercises?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PLRZ"],"gpt_icon":0},{"id":"2535770982","title":"Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2535770982","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535770982?lang=en_us&edition=fundamental","pubTime":"2025-05-13 22:33","pubTimestamp":1747146820,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/05/45379381/nasdaq-rises-over-1-under-armour-posts-strong-q4-sales","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AFMD",".IXIC","HCWB","ICCT","NDAQ","UAA","LOBO","AFMDQ","PLRZ","DEVS","UA"],"gpt_icon":0},{"id":"2535596722","title":"Polyrizon Ltd. Initiates Preclinical Studies for Innovative Intranasal Benzodiazepine Treatment Targeting $3.15 Billion Epilepsy Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2535596722","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535596722?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:45","pubTimestamp":1747136712,"startTime":"0","endTime":"0","summary":"Polyrizon Ltd. Initiates Preclinical Studies for Innovative Intranasal Benzodiazepine Treatment Targeting $3.15 Billion Epilepsy Market. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Polyrizon Ltd. published the original content used to generate this news brief via GlobeNewswire  on May 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL3kJGjQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","PLRZ"],"gpt_icon":0},{"id":"2535228517","title":"Polyrizon Targets $3.15B Epilepsy Market With Preclinical Studies for Innovative Rescue Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535228517","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535228517?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:45","pubTimestamp":1747136700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nTUA8Z1Z7K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PLRZ"],"gpt_icon":0},{"id":"2532824283","title":"Polyrizon Shares Surge After Dropping Reverse Stock Split Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2532824283","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532824283?lang=en_us&edition=fundamental","pubTime":"2025-05-03 00:22","pubTimestamp":1746202938,"startTime":"0","endTime":"0","summary":"Polyrizon  shares surged more than 211% in recent Friday trading, a day after the biotech company announced that it has cancelled its planned 1-for-10 reverse stock split.Trading volume stood at more than 249.9 million shares against a daily average of about 372,000 shares.Price: 0.79, Change: +0.54, Percent Change: +211.37","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PLRZ"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PLRZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-27","symbol":"PLRZ","defaultRemindTime":1748352600000,"type":"split","dateTimestamp":1748318400000,"forFactor":250,"toFactor":1,"ratio":250}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PLRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PLRZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PLRZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PLRZ","date":"2025-07-15","current":-2.352398,"percent":0.626437,"low":-29.515607,"twenty":-4.745183,"median":-3.029087,"eighty":-0.93608,"high":-0.011381,"avg":-3.111129,"sd":3.039769,"marketCap":3634455},"quantilePoints":[{"date":"2024-10-31","current":-13.097935,"twenty":-22.948538,"median":-13.097935,"eighty":-12.489816,"marketCap":7858761},{"date":"2024-11-08","current":-3.903419,"twenty":-12.692522,"median":-4.690878,"eighty":-4.316449,"marketCap":3891709},{"date":"2024-11-15","current":-2.661127,"twenty":-9.219549,"median":-4.249136,"eighty":-3.530862,"marketCap":2653144},{"date":"2024-11-22","current":-2.985655,"twenty":-4.737156,"median":-3.736612,"eighty":-3.09924,"marketCap":2976698},{"date":"2024-11-29","current":-3.042447,"twenty":-4.451075,"median":-3.375089,"eighty":-3.037515,"marketCap":3033320},{"date":"2024-12-06","current":-3.212824,"twenty":-4.383762,"median":-3.342636,"eighty":-3.042447,"marketCap":3203186},{"date":"2024-12-13","current":-3.375088,"twenty":-4.191157,"median":-3.358862,"eighty":-3.047315,"marketCap":3364963},{"date":"2024-12-20","current":-7.561496,"twenty":-4.383762,"median":-3.375088,"eighty":-3.07146,"marketCap":7538812},{"date":"2024-12-27","current":-5.744141,"twenty":-5.095085,"median":-3.407542,"eighty":-3.090153,"marketCap":5726909},{"date":"2025-01-03","current":-5.938858,"twenty":-6.101122,"median":-3.569805,"eighty":-3.132991,"marketCap":5921041},{"date":"2025-01-10","current":-4.997727,"twenty":-6.159537,"median":-3.796975,"eighty":-3.146231,"marketCap":4982734},{"date":"2025-01-17","current":-6.142316,"twenty":-6.098128,"median":-3.933764,"eighty":-3.167391,"marketCap":6123889},{"date":"2025-01-24","current":-5.889893,"twenty":-6.192801,"median":-4.333277,"eighty":-3.193353,"marketCap":5872223},{"date":"2025-01-31","current":-5.553327,"twenty":-6.125488,"median":-4.527162,"eighty":-3.214122,"marketCap":5536667},{"date":"2025-02-07","current":-4.552045,"twenty":-6.087615,"median":-4.738105,"eighty":-3.227753,"marketCap":4538389},{"date":"2025-02-14","current":-4.711914,"twenty":-6.064471,"median":-4.705652,"eighty":-3.245278,"marketCap":4697778},{"date":"2025-02-21","current":-4.522596,"twenty":-6.049761,"median":-4.627772,"eighty":-3.258259,"marketCap":4509028},{"date":"2025-02-28","current":-3.707687,"twenty":-6.000655,"median":-4.535397,"eighty":-3.316674,"marketCap":3696564},{"date":"2025-03-07","current":-3.460732,"twenty":-5.929065,"median":-4.501561,"eighty":-3.241954,"marketCap":3450350},{"date":"2025-03-14","current":-1.846098,"twenty":-5.873065,"median":-4.396383,"eighty":-3.213473,"marketCap":2852222},{"date":"2025-03-21","current":-1.508371,"twenty":-5.793429,"median":-4.291207,"eighty":-3.160314,"marketCap":2330433},{"date":"2025-03-28","current":-1.353625,"twenty":-5.705978,"median":-3.977976,"eighty":-3.07146,"marketCap":2091350},{"date":"2025-04-04","current":-0.974631,"twenty":-5.536499,"median":-3.903419,"eighty":-3.030526,"marketCap":1505805},{"date":"2025-04-11","current":-0.980061,"twenty":-5.4398,"median":-3.702849,"eighty":-2.640357,"marketCap":1514194},{"date":"2025-04-17","current":-0.985491,"twenty":-5.322255,"median":-3.619184,"eighty":-1.846098,"marketCap":1522583},{"date":"2025-04-25","current":-0.947483,"twenty":-5.174691,"median":-3.5049,"eighty":-1.520317,"marketCap":1463861},{"date":"2025-05-02","current":-0.687943,"twenty":-5.159991,"median":-3.434137,"eighty":-1.353625,"marketCap":1062872},{"date":"2025-05-09","current":-2.602277,"twenty":-5.095085,"median":-3.375088,"eighty":-1.466019,"marketCap":4020518},{"date":"2025-05-16","current":-0.039201,"twenty":-5.02132,"median":-3.354145,"eighty":-1.299871,"marketCap":60566},{"date":"2025-05-23","current":-0.018499,"twenty":-5.006408,"median":-3.310183,"eighty":-1.057434,"marketCap":28581},{"date":"2025-05-30","current":-0.022023,"twenty":-4.999463,"median":-3.245278,"eighty":-1.021327,"marketCap":34025},{"date":"2025-06-06","current":-0.014912,"twenty":-4.937359,"median":-3.214447,"eighty":-0.978975,"marketCap":23039},{"date":"2025-06-13","current":-0.018851,"twenty":-4.922267,"median":-3.183486,"eighty":-0.945854,"marketCap":29125},{"date":"2025-06-20","current":-0.013358,"twenty":-4.871782,"median":-3.155299,"eighty":-0.895899,"marketCap":20638},{"date":"2025-06-27","current":-2.431375,"twenty":-4.817057,"median":-3.116926,"eighty":-0.895899,"marketCap":3756474},{"date":"2025-07-03","current":-2.428961,"twenty":-4.79003,"median":-3.054617,"eighty":-0.90676,"marketCap":3752744},{"date":"2025-07-11","current":-2.469311,"twenty":-4.75787,"median":-3.036282,"eighty":-0.929565,"marketCap":3815085},{"date":"2025-07-15","current":-2.352398,"twenty":-4.745183,"median":-3.029087,"eighty":-0.93608,"marketCap":3634455}],"updateTime":1752719096252}}}